Alerts will be sent to your verified email
Verify Email
ISHITADR
|
Ishita Drugs & Inds.
|
Venmax Drugs&Pharma
|
Zenith Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.38 % | -46.46 % | 3.1 % |
|
5yr average Equity Multiplier
|
1.27 | 0.08 | 1.38 |
|
5yr Average Asset Turnover Ratio
|
1.23 | 0.14 | 1.51 |
|
5yr Avg Net Profit Margin
|
5.43 % | -19.62 % | 1.44 % |
|
Price to Book
|
1.87 | 2.45 | 2.39 |
|
P/E
|
21.59 | 60.68 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
74.52 Days | 288.55 Days | 46.26 Days |
|
Inventory Days
|
35.08 Days | 5.2 Days | 71.2 Days |
|
Days Receivable
|
31.6 Days | 430.69 Days | 75.61 Days |
|
Days Payable
|
42.7 Days | 141.12 Days | 64.53 Days |
|
5yr Average Interest Coverage Ratio
|
24.46 | -260.56 | 35.13 |
|
5yr Avg ROCE
|
11.48 % | -47.43 % | 5.45 % |
|
5yr Avg Operating Profit Margin
|
6.66 % | -65.91 % | 1.4 % |
|
5 yr average Debt to Equity
|
0.09 | -0.45 | 0.0 |
|
5yr CAGR Net Profit
|
0.95 % | -42.57 % | -30.76 % |
|
5yr Average Return on Assets
|
6.68 % | 199.45 % | 2.29 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.04 % | 15.14 % | 28.74 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.72 % | -7.99 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ishita Drugs & Inds.
|
Venmax Drugs&Pharma
|
Zenith Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|